HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.

Abstract
It has been reported that ischemic postconditioning (PC) changes the reperfusion pattern in permanent or transient models of stroke and confers neuroprotection. However, the effects of PC and subsequent use of tissue plasminogen activator (tPA) for the treatment of embolic stroke have not yet been investigated. Rats were subjected to stroke by injection of a preformed clot into the middle cerebral artery and randomly assigned to vehicle (saline 0.1 ml/100 g), tPA (3 mg/kg), PC only or PC+tPA (3 mg/kg). tPA was injected at 6 h after embolic stroke and PC was conducted at 6.5 h after ischemia by using five cycles of a 10 s occlusion and 30 s of reopening of the bilateral common carotid arteries. Cerebral blood flow (CBF) was monitored for 60 min from the time of tPA injection. Infarct size, blood brain barrier disruption, edema, neurological deficits, reactive oxygen species and apoptosis were measured 2 days later. PC decreased infarct volume, but PC+tPA was more neuroprotective than PC alone. While tPA alone dramatically increased CBF, conducting PC caused a gradual increase in CBF. A combination of PC+tPA reduced BBB leakage, brain edema, apoptosis and reactive oxygen species levels. Furthermore, a combination of PC+tPA improved neurological functions at 48 h after the induced stroke. In conclusion, PC hampered malignant hyperemia after reperfusion with tPA and extended its therapeutic window up to 6 h. Compared to PC alone, combination of thrombolysis and PC showed a better neuroprotection.
AuthorsAli Esmaeeli-Nadimi, Derek Kennedy, Mohammad Allahtavakoli
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 764 Pg. 55-62 (Oct 05 2015) ISSN: 1879-0712 [Electronic] Netherlands
PMID26123846 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Tissue Plasminogen Activator
Topics
  • Animals
  • Apoptosis (drug effects)
  • Behavior, Animal (drug effects)
  • Blood-Brain Barrier (drug effects, metabolism)
  • Brain Edema (complications, prevention & control)
  • Cerebral Infarction (complications, prevention & control)
  • Cerebrovascular Circulation (drug effects)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Embolism (complications)
  • Hyperemia (complications, prevention & control)
  • Ischemic Postconditioning (methods)
  • Male
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Wistar
  • Reperfusion
  • Stroke (complications, pathology, physiopathology, therapy)
  • Time Factors
  • Tissue Plasminogen Activator (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: